This document provides an overview of macrocytic anemia, focusing on deficiencies in cobalamin and folate. It describes the etiology, absorption, clinical features, hematologic findings, diagnosis, and other causes of macrocytic anemia. Cobalamin and folate deficiencies can result in megaloblastic changes in the bone marrow and ineffective hematopoiesis. Diagnosis involves measuring serum levels of cobalamin, folate, methylmalonic acid and homocysteine, along with tests to determine the underlying cause of deficiency. Other potential causes of macrocytic anemia include vitamin B6 deficiency, acute infections, drugs, toxins, acute myeloid leukemia, and genetic disorders.
causes of macrocytic anemia pathopysiology, sign and symptoms and the difference between macrocytic anemia megaloblastIc anemia. causes of hypersegmented neutrophils and its association between them. investigation and medical management plus pictures illustration.
UAEU - CMHS - Hematology-Oncology Course - MMH 302 - HONC 320. Education material for medical students - It cover basic principles of hematology and oncology, including CAR-T and gene editing. It can be used for study and review. It illustrates main principles of hematology and oncology.
causes of macrocytic anemia pathopysiology, sign and symptoms and the difference between macrocytic anemia megaloblastIc anemia. causes of hypersegmented neutrophils and its association between them. investigation and medical management plus pictures illustration.
UAEU - CMHS - Hematology-Oncology Course - MMH 302 - HONC 320. Education material for medical students - It cover basic principles of hematology and oncology, including CAR-T and gene editing. It can be used for study and review. It illustrates main principles of hematology and oncology.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. The megaloblastic anemias
are a group of disorders
characterized by the
presence of distinctive
morphologic appearances
of the developing red cells
in the bone marrow.
Bone marrow usually
produces large, structurally
abnormal, immature red
blood cells due to impaired
DNA synthesis.
The marrow is usually
hypercellular and the
anemia is based on
ineffective erythropoiesis.
4. Cobalamin
Has a cobalt atom at the center of a corrin ring.
Adocobalamin and methylcobalamin forms are major
natural cobalamin.
Minor amounts of hydroxocobalamin to which methyl- and
adocobalamin are converted rapidly by exposure to light.
5. Absorption of Cobalamin
Two mechanism,
1) Passive, occurring equally through buccal, duodenal, and
ileal mucosa; it is rapid but extremely inefficient, with <1%
of an oral dose being absorbed by this process.
2) Active; it occurs through the ileum and is efficient for
small (a few micrograms) oral doses of cobalamin, and it is
mediated by gastric intrinsic factor (IF).
6.
7.
8.
9. Folate
Folic (pteroylglutamic) acid is a yellow, crystalline, water-
soluble substance.
The highest concentrations are found in liver, yeast,
spinach, other greens, and nuts (>100 μg/100 g).
Folate is easily destroyed by heating, particularly in large
volumes of water.
Total body folate in the adult is ~10 mg, with the liver
containing the largest store.
10. Daily adult requirements are ~100 μg, and so stores are
sufficient for only 3–4 months in normal adults.
Folates are absorbed rapidly from the upper small
intestine.
11.
12. Clinical Features
Many symptomless patients are detected through the
finding of a raised mean corpuscular volume (MCV) on a
routine blood count.
Anorexia is usually marked, and there may be weight loss,
diarrhea, or constipation.
Glossitis, angular cheilosis, a mild fever in more severely
anemic patients, jaundice (unconjugated), and reversible
melanin skin hyperpigmentation also may occur.
13. Neurologic Manifestations
Vitamin B12 is needed for the myelination of the central
nervous system.
Its deficiency may cause a bilateral peripheral neuropathy
or degeneration (demyelination) of the cervical and
thoracic posterior and lateral (pyramidal) tracts of the
spinal cord and, less frequently, of the cranial nerves and
of the white matter of the brain.
Optic atrophy and cerebral symptoms including dementia,
depression, psychotic symptoms, and cognitive impairment
may be prominent.
14. MRI may show the “spongy” degeneration of the cord.
Loss of proprioception and vibration sensation with
positive Romberg and Lhermitte signs.
Gait may be ataxic with spasticity (hyperreflexia).
Autonomic nervous dysfunction can result in postural
hypotension, impotence, and incontinence
Cobalamin deficiency in infancy:poor brain
development,impaired intellectual development,feeding
difficulties, lethargy, coma,convulsions and myoclonus.
15. Cardiovascular Disease:
severe homocystinuria (blood levels ≥100 μmol/L)
due to deficiency of one of three enzymes,
methionine synthase, MTHFR, or cystathionine
synthase ischemic heart disease, cerebrovascular
disease, or pulmonary embolus or deep vein
thrombosis in young.
16. HEMATOLOGIC FINDINGS
PERIPHERAL BLOOD :
Oval macrocytes, with anisocytosis and
poikilocytosis
The MCV is usually >100 fL.
Neutrophils are hypersegmented (more than five
nuclear lobes).
Leukopenia due to a reduction in granulocytes and
lymphocytes.
Platelet count may be moderately reduced.
17. BONE MARROW :
Hypercellular with an accumulation of primitive cells
.Cells are larger than normoblasts, and an increased
number of cells with eccentric lobulated nuclei or
nuclear fragments.
Giant and abnormally shaped metamyelocytes and
enlarged hyperpolyploid megakaryocytes are
characteristic.
18. CHROMOSOMES
Proliferating cells in the body show : random breaks,
reduced contraction, spreading of the centromere,
and exaggeration of secondary chromosomal
constrictions and overprominent satellites.
INEFFECTIVE HEMATOPOIESIS :
unconjugated bilirubin in plasma ,raised urine
urobilinogen, reduced haptoglobins and positive
urine hemosiderin,raised serum lactate
dehydrogenase,weakly positive direct antiglobulin
test due to complement.
19. DIAGNOSIS OF COBALAMIN AND
FOLATE DEFICIENCIES
COBALAMIN DEFICIENCY :
Serum Cobalamin normal levels :160–200 ng/L
to 1000 ng/L.
In patients with megaloblastic anemia due to
cobalamin deficiency, the level is usually <100
ng/L.
Borderline :100 to 200 ng/L.
Serum cobalamin level is sufficiently robust, cost-
effective, and most convenient to rule out
cobalamin deficiency .
But where clinical indications of pernicious
anemia( PA) are strong, a normal serum vitamin
B12 does not rule out the diagnosis.
20. Folate deficiency, transcobalamin 1 deficiency, oral
contraceptives, and multiple myeloma have all been
associated with low serum B12 levels that do not
indicate B12 deficiency.
High serum B12 levels : serum transcobalamin 1
levels raised presence of liver, renal, or
myeloproliferative diseases or to cancer of the
breast, colon, or liver.
Serum Methylmalonate(MMA) and Homocysteine:
elevated.
Serum homocysteine: raised
but may be raised in chronic renal disease,
alcoholism, smoking, pyridoxine deficiency,
hypothyroidism,therapy with steroids, cyclosporine,
and other drugs
21. Tests for the Cause of Cobalamin Deficiency :
Only strict vegetarians, or people living on a totally
inadequate diet will be B12 deficient because of
inadequate intake.
Tests to diagnose PA : serum gastrin,( raised) serum
pepsinogen I (low) in PA (90–92%) and gastric
endoscopy.
Tests for IF and parietal cell antibodies
Tests for individual intestinal diseases.
22. FOLATE DEFICIENCY :
Serum Folate: Normal range 2 μg/L to 15 μg/L.
The serum folate level is low in all folate-deficient
patients
Serum folate rises in severe cobalamin deficiency
because of the block in conversion of MTHF to THF
inside cells,also in intestinal stagnant loop syndrome
Red Cell Folate :Test of body folate stores.
Normal (160–640 μg/L) of packed red cells.
Serum homocysteine elevated.
Tests for the Cause of Folate Deficiency :
Diet history
Tests for transglutaminase antibodies for celiac disease
/duodenal biopsy as needed.
23. HEMATOLOGICAL FINDINGS
PERIPHERAL BLOOD
Oval macrocytes, usually with considerable anisocytosis
and poikilocytosis, are the main feature.
The MCV is usually >100 Fl unless a cause of microcytosis
(e.g., iron deficiency or thalassemia trait) is present.
Some of the neutrophils are hypersegmented (more than
five nuclear lobes).
24. There may be leukopenia due to a reduction in
granulocytes and lymphocytes, but this is usually >1.5 ×
109/L.
platelet count may be moderately reduced, rarely to <40 ×
109/L.
The severity of all these changes parallels the degree of
anemia.
25. OTHER CAUSES OF MACROCYTIC
ANEMIA
Vitamin B6 deficiency: assessed by a therapeutic
trial of pyridoxine
Acute viral infections, drug reactions, or chemical
toxicity( transient).
AML :20% blasts in the marrow
Genetic diseases:genomic testing